ARCHIVES

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO, NCCS form cancer quality alliance.

November 11, 2005

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

DRCCA Board, ACCI Agree On New Core Grant Guidelines

February 6, 1981

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013